Cumberland Pharmaceuticals Inc.
CPIX
$5.72
-$0.14-2.39%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.38M | -2.84M | -3.33M | -2.93M | -3.28M |
| Total Depreciation and Amortization | 5.53M | 5.29M | 5.74M | 5.82M | 5.92M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 241.60K | 319.70K | -196.90K | -905.90K | -1.04M |
| Change in Net Operating Assets | 3.03M | 2.16M | 4.62M | 5.14M | 3.81M |
| Cash from Operations | 1.42M | 4.93M | 6.83M | 7.12M | 5.42M |
| Capital Expenditure | -50.30K | -97.90K | -100.20K | -91.80K | -72.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.49M | -4.61M | -1.56M | -687.70K | -1.04M |
| Cash from Investing | -3.54M | -4.71M | -1.66M | -779.50K | -1.11M |
| Total Debt Issued | -- | -- | 5.50M | 16.49M | 27.49M |
| Total Debt Repaid | 0.00 | -10.04M | -16.35M | -27.34M | -38.33M |
| Issuance of Common Stock | 0.00 | 5.27M | 5.27M | 5.27M | 5.27M |
| Repurchase of Common Stock | -78.60K | -263.50K | -361.90K | -450.30K | -577.30K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.90M | -1.71M | -1.50M | -1.56M | -1.60M |
| Cash from Financing | -1.98M | -6.75M | -7.44M | -7.59M | -7.75M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.10M | -6.52M | -2.27M | -1.25M | -3.44M |